Allogeneic Transplantation
Myelodysplastic Syndrome Trials (MDS & CMML)
COMIRB: 22-0130
A Phase 1, Open-Label, Safety and Tolerability Study of INCB057643 in Participants with Myelofibrosis and Other Advanced Myeloid Neoplasms
PI: Brandon McMahon
Eligibility: Ages ≥ 18; Relapsed or refractory MF, MDS, or MDS/MPN (Part 1); ECOG of ≤2
COMIRB: 24-1444
2. A Controlled Multi-Arm Phase 1 Umbrella Study Evaluating the Safety and Feasibility of T-Cell Receptor Engineered Donor T-Cells Targeting HA-1 (TSC-100) or HA-2 (TSC-101) in HLA-A*02:01 Positive Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation
PI: Mat Angelos
Eligibility: Undergoing allogeneic HCT for either of the following: • AML (including mixed phenotype acute leukemia) • MDS • ALL *please see other eligibility details
Request an Appointment
If you would like to schedule an appointment, please give us a call.
Our intake coordinator will help you navigate the process of becoming a new patient including helping you obtain the necessary referrals, get the necessary medical records transferred, and coordinate care with your existing physicians. We are available to answer your questions about our clinic, your treatment, and participation in ongoing clinical trials.